

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.56993449 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.56993449 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.29978227 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.29978227 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.83448526 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.77827903 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.60280435 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.46684199 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.34794743 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.28066775 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.25862207 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.23441947 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 5.14246225 |
| 14 | lysine catabolic process (GO:0006554) | 5.14175398 |
| 15 | lysine metabolic process (GO:0006553) | 5.14175398 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.08800209 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.08800209 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.08800209 |
| 19 | urea cycle (GO:0000050) | 5.02735445 |
| 20 | urea metabolic process (GO:0019627) | 5.02735445 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95557730 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.89702422 |
| 23 | protein carboxylation (GO:0018214) | 4.89388657 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89388657 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.87031127 |
| 26 | cysteine metabolic process (GO:0006534) | 4.79482832 |
| 27 | tryptophan metabolic process (GO:0006568) | 4.78342177 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.76275894 |
| 29 | regulation of fibrinolysis (GO:0051917) | 4.66818427 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.60216494 |
| 31 | ethanol oxidation (GO:0006069) | 4.54006950 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.53221450 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.49217310 |
| 34 | regulation of complement activation (GO:0030449) | 4.45380586 |
| 35 | bile acid metabolic process (GO:0008206) | 4.40437081 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.38262141 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.36033092 |
| 38 | mannose metabolic process (GO:0006013) | 4.34515776 |
| 39 | GDP-mannose metabolic process (GO:0019673) | 4.34196827 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.33971026 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25879891 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.25879891 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.25879891 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.22740609 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 4.22194718 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.17179998 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.15738685 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.15738685 |
| 49 | glycine metabolic process (GO:0006544) | 4.13522118 |
| 50 | valine metabolic process (GO:0006573) | 4.12816948 |
| 51 | serine family amino acid biosynthetic process (GO:0009070) | 4.11790967 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.08434051 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.08434051 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 4.07570362 |
| 55 | phospholipid efflux (GO:0033700) | 4.06415313 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.05342884 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 4.01754966 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.00610587 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 3.99271902 |
| 60 | adenosine receptor signaling pathway (GO:0001973) | 3.91090740 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.87691633 |
| 62 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87471727 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.86110538 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.85691499 |
| 65 | acetyl-CoA metabolic process (GO:0006084) | 3.75200832 |
| 66 | regulation of cholesterol homeostasis (GO:2000188) | 3.72279437 |
| 67 | L-serine metabolic process (GO:0006563) | 3.69285195 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 3.68643200 |
| 69 | cholesterol efflux (GO:0033344) | 3.68505302 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.66772290 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.66437465 |
| 72 | glutamate metabolic process (GO:0006536) | 3.64551903 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.64357623 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.62350553 |
| 75 | ethanol metabolic process (GO:0006067) | 3.59745705 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59360844 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59360844 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 3.58856324 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.56157634 |
| 80 | fatty acid oxidation (GO:0019395) | 3.52373152 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49844574 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.48023329 |
| 83 | organic acid catabolic process (GO:0016054) | 3.48023329 |
| 84 | protein-lipid complex assembly (GO:0065005) | 3.47232137 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.47121346 |
| 86 | response to peptidoglycan (GO:0032494) | 3.45992785 |
| 87 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.45683038 |
| 88 | lipid oxidation (GO:0034440) | 3.44517002 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 3.44509452 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.44481308 |
| 91 | bile acid and bile salt transport (GO:0015721) | 3.44465938 |
| 92 | arginine metabolic process (GO:0006525) | 3.44127032 |
| 93 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.42573935 |
| 94 | response to muramyl dipeptide (GO:0032495) | 3.40351897 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.40223485 |
| 96 | complement activation (GO:0006956) | 3.39829182 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.39722271 |
| 98 | fibrinolysis (GO:0042730) | 3.39423697 |
| 99 | fatty acid catabolic process (GO:0009062) | 3.39204034 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.38093454 |
| 101 | sterol homeostasis (GO:0055092) | 3.37270940 |
| 102 | regulation of skeletal muscle contraction (GO:0014819) | 3.36432598 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.34441879 |
| 104 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34365013 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 3.34228889 |
| 106 | amine catabolic process (GO:0009310) | 3.34228889 |
| 107 | carnitine metabolic process (GO:0009437) | 3.33238375 |
| 108 | primary alcohol catabolic process (GO:0034310) | 3.33141187 |
| 109 | negative regulation of cell killing (GO:0031342) | 3.33029024 |
| 110 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33029024 |
| 111 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32254438 |
| 112 | oxaloacetate metabolic process (GO:0006107) | 3.30487694 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.30230759 |
| 114 | ketone body metabolic process (GO:1902224) | 3.29563996 |
| 115 | UV protection (GO:0009650) | 3.28282456 |
| 116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.28047239 |
| 117 | detection of bacterium (GO:0016045) | 3.26717279 |
| 118 | proline biosynthetic process (GO:0006561) | 3.18778332 |
| 119 | regulation of synapse structural plasticity (GO:0051823) | 3.17395138 |
| 120 | protein insertion into membrane (GO:0051205) | 3.09941772 |
| 121 | detection of other organism (GO:0098543) | 3.06504277 |
| 122 | positive thymic T cell selection (GO:0045059) | 3.04113565 |
| 123 | purinergic receptor signaling pathway (GO:0035587) | 3.02072572 |
| 124 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.01726026 |
| 125 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99164666 |
| 126 | negative regulation of cell size (GO:0045792) | 2.98948025 |
| 127 | granulocyte differentiation (GO:0030851) | 2.98843655 |
| 128 | positive regulation of B cell differentiation (GO:0045579) | 2.96668766 |
| 129 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.96203988 |
| 130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.94312919 |
| 131 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.93626722 |
| 132 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.93431325 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 2.90681689 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.90240633 |
| 135 | negative regulation of innate immune response (GO:0045824) | 2.88660561 |
| 136 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87630197 |
| 137 | modulation by virus of host process (GO:0019054) | 2.86852034 |
| 138 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84432659 |
| 139 | thymic T cell selection (GO:0045061) | 2.82982939 |
| 140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76391714 |
| 141 | germinal center formation (GO:0002467) | 2.73898586 |
| 142 | regulation of leukocyte degranulation (GO:0043300) | 2.73839483 |
| 143 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71979722 |
| 144 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.71933399 |
| 145 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71132405 |
| 146 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71132405 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.71132405 |
| 148 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71132405 |
| 149 | modulation by symbiont of host defense response (GO:0052031) | 2.71132405 |
| 150 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71132405 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70305693 |
| 152 | regulation of cholesterol metabolic process (GO:0090181) | 2.70076447 |
| 153 | B cell receptor signaling pathway (GO:0050853) | 2.68107881 |
| 154 | negative regulation of interleukin-8 production (GO:0032717) | 2.65494603 |
| 155 | NIK/NF-kappaB signaling (GO:0038061) | 2.65450768 |
| 156 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.65259219 |
| 157 | amyloid precursor protein catabolic process (GO:0042987) | 2.65177817 |
| 158 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61980157 |
| 159 | adenine nucleotide transport (GO:0051503) | 2.61861125 |
| 160 | glycosphingolipid catabolic process (GO:0046479) | 2.61822321 |
| 161 | base-excision repair, AP site formation (GO:0006285) | 2.61649545 |
| 162 | N-acetylneuraminate metabolic process (GO:0006054) | 2.59964272 |
| 163 | amino sugar catabolic process (GO:0046348) | 2.58023445 |
| 164 | macrophage activation involved in immune response (GO:0002281) | 2.56725921 |
| 165 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56512561 |
| 166 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.56266791 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55571208 |
| 168 | iron-sulfur cluster assembly (GO:0016226) | 2.55491659 |
| 169 | metallo-sulfur cluster assembly (GO:0031163) | 2.55491659 |
| 170 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53392547 |
| 171 | regulation of regulated secretory pathway (GO:1903305) | 2.51631196 |
| 172 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.49866884 |
| 173 | modulation by symbiont of host cellular process (GO:0044068) | 2.49212130 |
| 174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48337140 |
| 175 | Golgi transport vesicle coating (GO:0048200) | 2.47899051 |
| 176 | COPI coating of Golgi vesicle (GO:0048205) | 2.47899051 |
| 177 | detection of external biotic stimulus (GO:0098581) | 2.47465986 |
| 178 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47277052 |
| 179 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.47094430 |
| 180 | Peyers patch development (GO:0048541) | 2.47094430 |
| 181 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.46986945 |
| 182 | dosage compensation (GO:0007549) | 2.43164346 |
| 183 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.41944838 |
| 184 | deoxyribonucleotide catabolic process (GO:0009264) | 2.41019935 |
| 185 | neutrophil activation involved in immune response (GO:0002283) | 2.40889766 |
| 186 | cellular response to interleukin-4 (GO:0071353) | 2.40208547 |
| 187 | pentose-phosphate shunt (GO:0006098) | 2.38882566 |
| 188 | T cell selection (GO:0045058) | 2.38797866 |
| 189 | cardiolipin metabolic process (GO:0032048) | 2.38407350 |
| 190 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.38263648 |
| 191 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.37172378 |
| 192 | creatine metabolic process (GO:0006600) | 2.36750413 |
| 193 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34432245 |
| 194 | response to misfolded protein (GO:0051788) | 2.34044812 |
| 195 | positive regulation of protein homooligomerization (GO:0032464) | 2.33927126 |
| 196 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.33024723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.55479950 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51888087 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.93824523 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.07508462 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92706715 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.74120349 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.18041581 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.00557613 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.40032335 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.02868690 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.45951554 |
| 12 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.15813418 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15003004 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05022975 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96989666 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89672599 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83533305 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79234400 |
| 19 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.77767933 |
| 20 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.72499986 |
| 21 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71952536 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70641835 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69725264 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68355909 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66976355 |
| 26 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65856886 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61706163 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59170844 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58825693 |
| 30 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.57655707 |
| 31 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.54371887 |
| 32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52666124 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51935390 |
| 34 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.47747215 |
| 35 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.47313434 |
| 36 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44562328 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41698102 |
| 38 | * MYC_22102868_ChIP-Seq_BL_Human | 1.40087437 |
| 39 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.38978147 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38449977 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38365234 |
| 42 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37487018 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37195705 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36900767 |
| 45 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36725224 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36068755 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35563952 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34115278 |
| 49 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.33447597 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33444645 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32955600 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30990761 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30280361 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28103816 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27301912 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27177265 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26625279 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25144515 |
| 59 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.24136363 |
| 60 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24063469 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22247329 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20917244 |
| 63 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.20808413 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20804185 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20471202 |
| 66 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20270408 |
| 67 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.19538039 |
| 68 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18266601 |
| 69 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.18186289 |
| 70 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17005009 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16305570 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15515005 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14017984 |
| 74 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.12651037 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12360679 |
| 76 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12128804 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12015900 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11102092 |
| 79 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11014708 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10785451 |
| 81 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08924419 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08357690 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08004651 |
| 84 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07722422 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07202890 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07035893 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06806172 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05806125 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05663330 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05532032 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05340126 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04810843 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 1.01247228 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00619480 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00112872 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99256895 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98819893 |
| 98 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97028311 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95826586 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95167399 |
| 101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91389433 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90667094 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89846320 |
| 104 | * P68_20966046_ChIP-Seq_HELA_Human | 0.88432722 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87598270 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85699059 |
| 107 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.85695116 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85064714 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84963827 |
| 110 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.84713752 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84289036 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83887102 |
| 113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82603721 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81769887 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81537810 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81512565 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80800417 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80730279 |
| 119 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80194060 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.78991075 |
| 121 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78240349 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78050820 |
| 123 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.78050820 |
| 124 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78017081 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.77889470 |
| 126 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77370539 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77362886 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76897791 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76203558 |
| 130 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74165262 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.73949518 |
| 132 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73050808 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.72599552 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72368132 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.71800708 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71358069 |
| 137 | MYB_26560356_Chip-Seq_TH1_Human | 0.70496548 |
| 138 | MAF_26560356_Chip-Seq_TH2_Human | 0.70323519 |
| 139 | * P300_27268052_Chip-Seq_Bcells_Human | 0.69477034 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69337861 |
| 141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.69304762 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69277533 |
| 143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.69132425 |
| 144 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.67971083 |
| 145 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67786571 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67782233 |
| 147 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67599508 |
| 148 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67463128 |
| 149 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.67424536 |
| 150 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.67420706 |
| 151 | ATF3_27146783_Chip-Seq_COLON_Human | 0.67405740 |
| 152 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67202515 |
| 153 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.66437219 |
| 154 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66315522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.91655352 |
| 2 | MP0005360_urolithiasis | 6.20677431 |
| 3 | MP0005365_abnormal_bile_salt | 5.44858818 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.26868064 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.23171156 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.89503762 |
| 7 | MP0009840_abnormal_foam_cell | 3.69866017 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.35079270 |
| 9 | MP0001986_abnormal_taste_sensitivity | 3.21028436 |
| 10 | MP0003252_abnormal_bile_duct | 3.20621235 |
| 11 | MP0009278_abnormal_bone_marrow | 3.15437760 |
| 12 | MP0005423_abnormal_somatic_nervous | 3.02944516 |
| 13 | MP0005083_abnormal_biliary_tract | 2.97116227 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.85050242 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.46250933 |
| 16 | MP0005332_abnormal_amino_acid | 2.34388062 |
| 17 | MP0003195_calcinosis | 2.28580654 |
| 18 | MP0000609_abnormal_liver_physiology | 2.23051406 |
| 19 | MP0008260_abnormal_autophagy | 2.19286655 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.17837849 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.17837849 |
| 22 | MP0000751_myopathy | 2.08804935 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.04931341 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.03532162 |
| 25 | MP0004381_abnormal_hair_follicle | 1.92507808 |
| 26 | MP0005171_absent_coat_pigmentation | 1.84936379 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.83277302 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.83001236 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.78657974 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.78619233 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.76052433 |
| 32 | MP0004130_abnormal_muscle_cell | 1.65294712 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58951070 |
| 34 | MP0001764_abnormal_homeostasis | 1.58221364 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.55621143 |
| 36 | MP0003724_increased_susceptibility_to | 1.54777163 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.49496733 |
| 38 | MP0002723_abnormal_immune_serum | 1.46346704 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.45375243 |
| 40 | MP0001819_abnormal_immune_cell | 1.44310425 |
| 41 | MP0005670_abnormal_white_adipose | 1.41321456 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.41056693 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.37824299 |
| 44 | MP0001790_abnormal_immune_system | 1.37174341 |
| 45 | MP0005387_immune_system_phenotype | 1.37174341 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.36911735 |
| 47 | MP0002398_abnormal_bone_marrow | 1.36724338 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.36386365 |
| 49 | MP0000598_abnormal_liver_morphology | 1.32881392 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.31728007 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.29400530 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.29336074 |
| 53 | MP0003868_abnormal_feces_composition | 1.28913604 |
| 54 | MP0008874_decreased_physiological_sensi | 1.27406872 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.26495189 |
| 56 | MP0003011_delayed_dark_adaptation | 1.22083306 |
| 57 | MP0000716_abnormal_immune_system | 1.21717641 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.19492428 |
| 59 | MP0005451_abnormal_body_composition | 1.18110334 |
| 60 | MP0002822_catalepsy | 1.17605251 |
| 61 | MP0002722_abnormal_immune_system | 1.17567810 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.16587967 |
| 63 | MP0000604_amyloidosis | 1.15523520 |
| 64 | MP0002429_abnormal_blood_cell | 1.15265230 |
| 65 | MP0002132_abnormal_respiratory_system | 1.13956273 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.13153917 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.11204283 |
| 68 | MP0001968_abnormal_touch/_nociception | 1.10450815 |
| 69 | MP0004859_abnormal_synaptic_plasticity | 1.08858421 |
| 70 | MP0008469_abnormal_protein_level | 1.08000726 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.07912957 |
| 72 | MP0003186_abnormal_redox_activity | 1.07874782 |
| 73 | MP0002971_abnormal_brown_adipose | 1.07404167 |
| 74 | MP0005310_abnormal_salivary_gland | 1.03155006 |
| 75 | MP0009763_increased_sensitivity_to | 1.02594826 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.02492211 |
| 77 | MP0001502_abnormal_circadian_rhythm | 1.02379885 |
| 78 | MP0001873_stomach_inflammation | 0.99280011 |
| 79 | MP0003111_abnormal_nucleus_morphology | 0.98506780 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.97761688 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.96685364 |
| 82 | MP0002269_muscular_atrophy | 0.93981473 |
| 83 | MP0009764_decreased_sensitivity_to | 0.93238987 |
| 84 | MP0002405_respiratory_system_inflammati | 0.93031678 |
| 85 | MP0000747_muscle_weakness | 0.92397767 |
| 86 | MP0005501_abnormal_skin_physiology | 0.90133230 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.89805964 |
| 88 | MP0001533_abnormal_skeleton_physiology | 0.88252557 |
| 89 | MP0000358_abnormal_cell_content/ | 0.87876950 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.87370779 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.86003292 |
| 92 | MP0003436_decreased_susceptibility_to | 0.85177637 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.84019164 |
| 94 | MP0004947_skin_inflammation | 0.83448775 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.82362854 |
| 96 | MP0009931_abnormal_skin_appearance | 0.82074932 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.81432347 |
| 98 | MP0005647_abnormal_sex_gland | 0.79731549 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.79057386 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.76570280 |
| 101 | MP0005266_abnormal_metabolism | 0.74196836 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.74138213 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.73317270 |
| 104 | MP0005334_abnormal_fat_pad | 0.73234432 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.72909430 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.72433085 |
| 107 | MP0000858_altered_metastatic_potential | 0.72118248 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.72015654 |
| 109 | MP0000685_abnormal_immune_system | 0.71670719 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.71090220 |
| 111 | MP0005671_abnormal_response_to | 0.70724243 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.70246415 |
| 113 | MP0006082_CNS_inflammation | 0.69764650 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.69636477 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.68647197 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.68572524 |
| 117 | MP0003690_abnormal_glial_cell | 0.67080392 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.66768177 |
| 119 | MP0002254_reproductive_system_inflammat | 0.66705444 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.66370570 |
| 121 | MP0003329_amyloid_beta_deposits | 0.64819536 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.64036516 |
| 123 | MP0009697_abnormal_copulation | 0.63922265 |
| 124 | MP0001853_heart_inflammation | 0.63572913 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.63311547 |
| 126 | MP0000749_muscle_degeneration | 0.62975590 |
| 127 | MP0001661_extended_life_span | 0.61358738 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.60689008 |
| 129 | MP0001756_abnormal_urination | 0.59067411 |
| 130 | MP0005330_cardiomyopathy | 0.58584540 |
| 131 | MP0005535_abnormal_body_temperature | 0.58571140 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.58319566 |
| 133 | MP0004147_increased_porphyrin_level | 0.58074125 |
| 134 | MP0004087_abnormal_muscle_fiber | 0.57836213 |
| 135 | MP0001243_abnormal_dermal_layer | 0.57600521 |
| 136 | MP0005025_abnormal_response_to | 0.57314732 |
| 137 | MP0002970_abnormal_white_adipose | 0.57166725 |
| 138 | MP0009115_abnormal_fat_cell | 0.55667879 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.55188777 |
| 140 | MP0005448_abnormal_energy_balance | 0.55034937 |
| 141 | MP0001800_abnormal_humoral_immune | 0.54888156 |
| 142 | MP0008873_increased_physiological_sensi | 0.54873127 |
| 143 | MP0009785_altered_susceptibility_to | 0.54100515 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.52587846 |
| 145 | MP0009672_abnormal_birth_weight | 0.51097180 |
| 146 | MP0002419_abnormal_innate_immunity | 0.49742819 |
| 147 | MP0001849_ear_inflammation | 0.49613350 |
| 148 | MP0005408_hypopigmentation | 0.47348070 |
| 149 | MP0000249_abnormal_blood_vessel | 0.44928168 |
| 150 | MP0003646_muscle_fatigue | 0.44275772 |
| 151 | MP0003303_peritoneal_inflammation | 0.43719958 |
| 152 | MP0000689_abnormal_spleen_morphology | 0.43482774 |
| 153 | MP0003075_altered_response_to | 0.41394256 |
| 154 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41371531 |
| 155 | MP0005166_decreased_susceptibility_to | 0.41368604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.39110589 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.96891983 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.66727378 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.42144486 |
| 5 | Xanthomatosis (HP:0000991) | 5.36432188 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.34010719 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.91863130 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.68821930 |
| 9 | Complement deficiency (HP:0004431) | 4.59405581 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.17580910 |
| 11 | Ketosis (HP:0001946) | 4.07060990 |
| 12 | Hyperammonemia (HP:0001987) | 4.06275630 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 3.93309316 |
| 14 | Testicular atrophy (HP:0000029) | 3.93304846 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.85244419 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.82315218 |
| 17 | Joint hemorrhage (HP:0005261) | 3.70148817 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.69976705 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.69201806 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.66773719 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54729965 |
| 22 | Epidermoid cyst (HP:0200040) | 3.53510911 |
| 23 | Thin bony cortex (HP:0002753) | 3.43378178 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.37289498 |
| 25 | Annular pancreas (HP:0001734) | 3.36848316 |
| 26 | Abnormality of complement system (HP:0005339) | 3.36824636 |
| 27 | Myopathic facies (HP:0002058) | 3.36170968 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34751005 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28908674 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28730462 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.25779011 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25203586 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.21259028 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.21259028 |
| 35 | Ketoacidosis (HP:0001993) | 3.19706422 |
| 36 | Fat malabsorption (HP:0002630) | 3.18872164 |
| 37 | Hyperglycinuria (HP:0003108) | 3.13228382 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.08646064 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.06343582 |
| 40 | Akinesia (HP:0002304) | 3.05809980 |
| 41 | Fetal akinesia sequence (HP:0001989) | 3.02412034 |
| 42 | Hyperglycinemia (HP:0002154) | 3.00215702 |
| 43 | Dyschromatopsia (HP:0007641) | 2.96813577 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.94457052 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.91608385 |
| 46 | Poikiloderma (HP:0001029) | 2.90967173 |
| 47 | Mesangial abnormality (HP:0001966) | 2.85260752 |
| 48 | Myoglobinuria (HP:0002913) | 2.84328185 |
| 49 | Myocardial infarction (HP:0001658) | 2.81435391 |
| 50 | Cholelithiasis (HP:0001081) | 2.80150601 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.79362911 |
| 52 | Ankle clonus (HP:0011448) | 2.77312731 |
| 53 | Abnormal gallbladder morphology (HP:0012437) | 2.71616404 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.71360373 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.70264357 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68665111 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68665111 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68665111 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66386682 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.66123633 |
| 61 | Gout (HP:0001997) | 2.65725763 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.63201515 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63201515 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.59532693 |
| 65 | Obstructive lung disease (HP:0006536) | 2.59193192 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59193192 |
| 67 | Anteriorly placed anus (HP:0001545) | 2.58244416 |
| 68 | Exercise-induced myalgia (HP:0003738) | 2.56470918 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.55877947 |
| 70 | Cholecystitis (HP:0001082) | 2.54293160 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.54293160 |
| 72 | Mitral stenosis (HP:0001718) | 2.53470931 |
| 73 | Petechiae (HP:0000967) | 2.53300181 |
| 74 | Facial diplegia (HP:0001349) | 2.53013616 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.52351497 |
| 76 | Exercise-induced muscle cramps (HP:0003710) | 2.50787505 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.50765224 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50765224 |
| 79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.50526917 |
| 80 | Easy fatigability (HP:0003388) | 2.49077146 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45939224 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45939224 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45939224 |
| 84 | Steatorrhea (HP:0002570) | 2.45231166 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44773134 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.44352776 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44150912 |
| 88 | Rhabdomyolysis (HP:0003201) | 2.44042456 |
| 89 | Skin nodule (HP:0200036) | 2.40971829 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 2.40605413 |
| 91 | Metabolic acidosis (HP:0001942) | 2.40411683 |
| 92 | Facial hemangioma (HP:0000329) | 2.39667277 |
| 93 | Spastic diplegia (HP:0001264) | 2.39653004 |
| 94 | Squamous cell carcinoma (HP:0002860) | 2.38400945 |
| 95 | Colitis (HP:0002583) | 2.38331426 |
| 96 | Late onset (HP:0003584) | 2.36447884 |
| 97 | Cellulitis (HP:0100658) | 2.35699042 |
| 98 | Hypertensive crisis (HP:0100735) | 2.32946247 |
| 99 | Acanthocytosis (HP:0001927) | 2.29648348 |
| 100 | Ulnar bowing (HP:0003031) | 2.29206897 |
| 101 | Rib fusion (HP:0000902) | 2.28719121 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.27273390 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 2.24890733 |
| 104 | Vascular calcification (HP:0004934) | 2.24162486 |
| 105 | Turricephaly (HP:0000262) | 2.23983207 |
| 106 | Gingival bleeding (HP:0000225) | 2.22403683 |
| 107 | Abnormality of serum amino acid levels (HP:0003112) | 2.21849202 |
| 108 | Basal cell carcinoma (HP:0002671) | 2.21612329 |
| 109 | Joint stiffness (HP:0001387) | 2.20888480 |
| 110 | Microvesicular hepatic steatosis (HP:0001414) | 2.20194198 |
| 111 | Spontaneous abortion (HP:0005268) | 2.19495065 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.17535656 |
| 113 | Abnormality of macrophages (HP:0004311) | 2.15598660 |
| 114 | Abnormality of the gallbladder (HP:0005264) | 2.14704404 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14434225 |
| 116 | Panhypogammaglobulinemia (HP:0003139) | 2.12802648 |
| 117 | Neonatal onset (HP:0003623) | 2.12140951 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 2.10905537 |
| 119 | Thrombophlebitis (HP:0004418) | 2.10235603 |
| 120 | Progressive muscle weakness (HP:0003323) | 2.09496042 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.09482416 |
| 122 | Stridor (HP:0010307) | 2.09354548 |
| 123 | Poikilocytosis (HP:0004447) | 2.08234089 |
| 124 | Recurrent fungal infections (HP:0002841) | 2.08013475 |
| 125 | Hemorrhage of the eye (HP:0011885) | 2.07376398 |
| 126 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.07151879 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 2.06421884 |
| 128 | Increased IgE level (HP:0003212) | 2.05821757 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05545314 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05011270 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05011270 |
| 132 | Lethargy (HP:0001254) | 2.04556686 |
| 133 | Progressive external ophthalmoplegia (HP:0000590) | 2.03973478 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 2.03692938 |
| 135 | Upper motor neuron abnormality (HP:0002127) | 2.03285085 |
| 136 | Meningitis (HP:0001287) | 2.02880275 |
| 137 | Seborrheic dermatitis (HP:0001051) | 2.01415185 |
| 138 | Popliteal pterygium (HP:0009756) | 2.01029474 |
| 139 | Reticulocytosis (HP:0001923) | 2.00981767 |
| 140 | Cardiovascular calcification (HP:0011915) | 2.00515576 |
| 141 | Myositis (HP:0100614) | 2.00355859 |
| 142 | Brushfield spots (HP:0001088) | 1.98131430 |
| 143 | Delayed CNS myelination (HP:0002188) | 1.97195574 |
| 144 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96419832 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96017171 |
| 146 | Pustule (HP:0200039) | 1.95672581 |
| 147 | Vaginal fistula (HP:0004320) | 1.95073707 |
| 148 | Amyloidosis (HP:0011034) | 1.94330783 |
| 149 | Upper limb amyotrophy (HP:0009129) | 1.93669238 |
| 150 | Distal upper limb amyotrophy (HP:0007149) | 1.93669238 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.92335002 |
| 152 | Epistaxis (HP:0000421) | 1.91655963 |
| 153 | Rapidly progressive (HP:0003678) | 1.91545457 |
| 154 | Generalized aminoaciduria (HP:0002909) | 1.91499245 |
| 155 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91440591 |
| 156 | Esophageal varix (HP:0002040) | 1.91162670 |
| 157 | Hyporeflexia of lower limbs (HP:0002600) | 1.90572248 |
| 158 | Respiratory difficulties (HP:0002880) | 1.90038835 |
| 159 | Hand muscle atrophy (HP:0009130) | 1.89824395 |
| 160 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.89674105 |
| 161 | Muscle fiber inclusion bodies (HP:0100299) | 1.89013761 |
| 162 | Pancreatitis (HP:0001733) | 1.88720790 |
| 163 | Progressive microcephaly (HP:0000253) | 1.88197418 |
| 164 | Irritability (HP:0000737) | 1.87529612 |
| 165 | Gastrointestinal inflammation (HP:0004386) | 1.87322603 |
| 166 | Widely patent fontanelles and sutures (HP:0004492) | 1.87114535 |
| 167 | Recurrent skin infections (HP:0001581) | 1.86840138 |
| 168 | Increased serum ferritin (HP:0003281) | 1.85620200 |
| 169 | Polycythemia (HP:0001901) | 1.84395911 |
| 170 | Gastrointestinal dysmotility (HP:0002579) | 1.83717501 |
| 171 | Delayed epiphyseal ossification (HP:0002663) | 1.83294813 |
| 172 | Diminished movement (HP:0002374) | 1.82880668 |
| 173 | Sensorimotor neuropathy (HP:0007141) | 1.82734563 |
| 174 | Hypertriglyceridemia (HP:0002155) | 1.82307535 |
| 175 | Abnormal cartilage morphology (HP:0002763) | 1.80785272 |
| 176 | Stroke (HP:0001297) | 1.80188911 |
| 177 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80056934 |
| 178 | Purpura (HP:0000979) | 1.79678784 |
| 179 | Glomerulonephritis (HP:0000099) | 1.78376143 |
| 180 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78248498 |
| 181 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78248498 |
| 182 | Opisthotonus (HP:0002179) | 1.77803334 |
| 183 | Increased purine levels (HP:0004368) | 1.76573871 |
| 184 | Hyperuricemia (HP:0002149) | 1.76573871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.09385996 |
| 2 | ERN1 | 4.31982610 |
| 3 | TRIB3 | 4.25654180 |
| 4 | PRPF4B | 3.91157850 |
| 5 | SIK1 | 3.69338828 |
| 6 | FGFR4 | 3.48705688 |
| 7 | PKN2 | 3.12952721 |
| 8 | MAPK15 | 2.67746151 |
| 9 | MAP4K1 | 2.42094730 |
| 10 | RIPK4 | 2.40756415 |
| 11 | TAOK3 | 2.33216405 |
| 12 | EEF2K | 2.29929795 |
| 13 | TTN | 2.27196283 |
| 14 | SMG1 | 2.12620086 |
| 15 | MAP3K10 | 2.03217081 |
| 16 | TYK2 | 2.02011962 |
| 17 | TNK2 | 1.93676406 |
| 18 | EPHA3 | 1.86550674 |
| 19 | MAP2K3 | 1.85886336 |
| 20 | FES | 1.66032225 |
| 21 | PDK3 | 1.61198501 |
| 22 | PDK4 | 1.61198501 |
| 23 | PTK6 | 1.60076782 |
| 24 | ZAP70 | 1.59652583 |
| 25 | MAP3K7 | 1.56475014 |
| 26 | NME2 | 1.48944823 |
| 27 | PIK3CG | 1.46347937 |
| 28 | MUSK | 1.45793795 |
| 29 | TBK1 | 1.45074745 |
| 30 | EPHB1 | 1.42673939 |
| 31 | MARK2 | 1.37646023 |
| 32 | MAPK11 | 1.36961382 |
| 33 | BLK | 1.32835160 |
| 34 | OBSCN | 1.31957959 |
| 35 | TAOK2 | 1.29195883 |
| 36 | LRRK2 | 1.27463672 |
| 37 | FLT3 | 1.25545241 |
| 38 | KDR | 1.22657061 |
| 39 | JAK1 | 1.16636844 |
| 40 | NEK1 | 1.16251145 |
| 41 | STK10 | 1.13404343 |
| 42 | IRAK4 | 1.08439270 |
| 43 | PIM2 | 1.07271335 |
| 44 | JAK2 | 1.05156418 |
| 45 | PRKD2 | 1.03695318 |
| 46 | GRK6 | 1.02754150 |
| 47 | PRKD3 | 1.01503063 |
| 48 | TGFBR2 | 1.00652800 |
| 49 | INSRR | 0.97407215 |
| 50 | KIT | 0.96652943 |
| 51 | BRD4 | 0.94754850 |
| 52 | FGFR2 | 0.93477247 |
| 53 | RIPK1 | 0.93281017 |
| 54 | TESK2 | 0.93250736 |
| 55 | IRAK2 | 0.91940826 |
| 56 | CSF1R | 0.91137566 |
| 57 | MAP3K3 | 0.89116931 |
| 58 | KSR2 | 0.86081544 |
| 59 | ICK | 0.84555920 |
| 60 | STK16 | 0.84396683 |
| 61 | NEK9 | 0.83341040 |
| 62 | MAP2K2 | 0.83340221 |
| 63 | CAMKK1 | 0.82472207 |
| 64 | MAPK12 | 0.81182154 |
| 65 | MAP3K1 | 0.80303184 |
| 66 | IKBKB | 0.79683735 |
| 67 | ITK | 0.78981425 |
| 68 | PAK6 | 0.77588064 |
| 69 | BTK | 0.77509667 |
| 70 | PDK2 | 0.75994124 |
| 71 | RPS6KA2 | 0.73737893 |
| 72 | TIE1 | 0.73258272 |
| 73 | PRKAA2 | 0.72092913 |
| 74 | DAPK2 | 0.70381373 |
| 75 | ERBB4 | 0.68610692 |
| 76 | RPS6KC1 | 0.65964941 |
| 77 | RPS6KL1 | 0.65964941 |
| 78 | IKBKE | 0.65585554 |
| 79 | JAK3 | 0.65539583 |
| 80 | TXK | 0.64737217 |
| 81 | DAPK1 | 0.64616122 |
| 82 | SIK2 | 0.64325345 |
| 83 | MAP3K11 | 0.64094394 |
| 84 | SGK3 | 0.62582812 |
| 85 | CDK4 | 0.61613149 |
| 86 | MTOR | 0.58590130 |
| 87 | SYK | 0.57325101 |
| 88 | NEK6 | 0.57122753 |
| 89 | FGFR3 | 0.56900642 |
| 90 | CSK | 0.56561792 |
| 91 | MAP2K6 | 0.56424250 |
| 92 | DYRK1B | 0.53758890 |
| 93 | CDK19 | 0.53535329 |
| 94 | MARK3 | 0.53428624 |
| 95 | MAP3K6 | 0.52525154 |
| 96 | CAMK1D | 0.52064593 |
| 97 | PRKCH | 0.51647502 |
| 98 | RET | 0.51568536 |
| 99 | PRKAA1 | 0.50717120 |
| 100 | HCK | 0.50496585 |
| 101 | GRK1 | 0.50101378 |
| 102 | HIPK2 | 0.49822969 |
| 103 | ERBB2 | 0.49726262 |
| 104 | PRKD1 | 0.49628880 |
| 105 | PDGFRA | 0.49161017 |
| 106 | MATK | 0.48444612 |
| 107 | * LYN | 0.48177732 |
| 108 | CDK6 | 0.48065633 |
| 109 | BMX | 0.47137851 |
| 110 | RPS6KA6 | 0.46590045 |
| 111 | MAPK7 | 0.46319124 |
| 112 | RAF1 | 0.45796288 |
| 113 | MST1R | 0.45685640 |
| 114 | MAPKAPK5 | 0.44825723 |
| 115 | PASK | 0.44215264 |
| 116 | SIK3 | 0.43441034 |
| 117 | LCK | 0.43370291 |
| 118 | PAK4 | 0.43221509 |
| 119 | MAPK4 | 0.43198730 |
| 120 | PHKG2 | 0.42656832 |
| 121 | PHKG1 | 0.42656832 |
| 122 | MAP3K14 | 0.42293627 |
| 123 | PDK1 | 0.41577111 |
| 124 | MAP3K13 | 0.41557391 |
| 125 | RPS6KA4 | 0.41244956 |
| 126 | RPS6KA1 | 0.40495118 |
| 127 | AURKA | 0.39778102 |
| 128 | ILK | 0.38928458 |
| 129 | TAOK1 | 0.38740864 |
| 130 | MAP2K4 | 0.38285438 |
| 131 | RPS6KA5 | 0.38134422 |
| 132 | FGFR1 | 0.37894579 |
| 133 | PDPK1 | 0.37123729 |
| 134 | TESK1 | 0.36075236 |
| 135 | CCNB1 | 0.35331478 |
| 136 | MAP3K8 | 0.35188817 |
| 137 | MAPKAPK3 | 0.34600814 |
| 138 | PINK1 | 0.34503261 |
| 139 | RPS6KB2 | 0.33807964 |
| 140 | PRKACG | 0.32527819 |
| 141 | PAK2 | 0.31434890 |
| 142 | MAP2K1 | 0.29449732 |
| 143 | SCYL2 | 0.26891202 |
| 144 | IRAK3 | 0.26716882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14392568 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.70621640 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28638865 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88646743 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83436207 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78206487 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72250694 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71251854 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54433727 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50635269 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47926161 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46420105 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.35877553 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27792795 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.11090385 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96259655 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94925317 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.91290772 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.89588724 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84408164 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.82350331 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74652300 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.73970010 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72664469 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72316690 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71504063 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71419873 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.68997581 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68666231 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67725101 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66692998 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66331003 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62432940 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61070132 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57446064 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56443706 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53177389 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51644840 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51483227 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47386392 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47111601 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45064416 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40384852 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39545151 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39489598 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33651319 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30993888 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30807841 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.25283436 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25215561 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.24453238 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21962839 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20533249 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.19571524 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.17751292 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16371512 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15801151 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15013759 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14423494 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12604272 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12154502 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.11846187 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11189341 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09503567 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01949091 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01682393 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98232563 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98172117 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97870988 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95248633 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93948134 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.91492103 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86708216 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85947543 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85933895 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85926959 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83744764 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82594294 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.81901994 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.78271274 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77578464 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76603248 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.76451350 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76276659 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75348915 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75152587 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71754349 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71043966 |
| 89 | * Endocytosis_Homo sapiens_hsa04144 | 0.70637940 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.69381270 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68915623 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68638536 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65719781 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.62656368 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.61837115 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61157111 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.59901968 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.59524275 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59264250 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59168159 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.59067457 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58854148 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56103262 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54970417 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54398137 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54337201 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53175043 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53111476 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51865635 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51585651 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50742865 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50630697 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49651381 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.47362688 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47331069 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47101081 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45901304 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43583325 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.42390495 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42289076 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42020620 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41629614 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41240354 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38403712 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38381253 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38044534 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37897783 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36748129 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35832652 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34780313 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32530900 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31284942 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21324560 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.19868329 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19197589 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15173892 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13483828 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13251733 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12518269 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.10801884 |
| 141 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.08786881 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.08415362 |
| 143 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05662110 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04998226 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.04460623 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00521929 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | -0.1525502 |
| 148 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1519742 |
| 149 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | -0.1362958 |
| 150 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1150486 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1112606 |
| 152 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1109617 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0736661 |
| 154 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0684823 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | -0.0548248 |
| 156 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0494859 |
| 157 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0422821 |
| 158 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0017313 |

